Skip to main content
Clinical Trials/CTRI/2024/06/068675
CTRI/2024/06/068675
Not yet recruiting
Phase 2

A Comparative Clinical Study To Evaluate The Effect Of Yashtimadhu Bhavita Shilajatu and Balamoola Bhavita Shilajatu In Diabetic Peripheral Neuropathy - nil

Dr Rakesh0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr Rakesh
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Dr Rakesh

Eligibility Criteria

Inclusion Criteria

  • Metabolically stable diabetic Subjects with symptomatic Diabetic Peripheral Neuropathy.
  • Subjects fulfilling the diagnostic criteria.
  • Subjects whose HbA1c is between 6\.5 to 9%.
  • Subjects of all gender between the age group of 40 \- 65 years

Exclusion Criteria

  • Subjects whose HbA1c is more than 9%.
  • Subjects with other metabolic and endocrinal disorders.
  • Subjects with other causes of Polyneuropathy.
  • Subjects suffering from infectious diseases and non healing ulcer/ulcers.
  • Subjects with cardiac aliments and Nephropathy.
  • Subjects with Diabetic Neuropathy in stage N3 of Dyck’s staging

Outcomes

Primary Outcomes

Not specified

Similar Trials